lilly
CHMP recommends Jardiance
March 24, 2014Research and Development, Sales and Marketing Boehringer, CHMP, EU, diabetes, jardiance, lilly
Boehringer Ingelheim and Eli Lilly’s type 2 diabetes treatment Jardiance is among nine medicines which the Committee for Medicinal Products …
Major new launches for 2014
March 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10
AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …
GSK tops drug approval rates
March 7, 2014Medical Communications, Sales and Marketing FDA, GSK, J&J, JJ, Merck, Sanofi, ep, evaluate pharma, lilly, nme
GlaxoSmithKline is riding high when it comes to the approval of new medicines but US firm Lilly is falling behind. …
Manufacturing hitches cited for Lilly/BI drug rejection
March 6, 2014Manufacturing and Production, Sales and Marketing Boehringer, FDA, diabetes, lilly, manufacturing
The FDA has refused to approve a new diabetes treatment from Lilly and its partner Boehringer Ingelheim due to ongoing …
NICE rejects Alimta
February 28, 2014Sales and Marketing Alimta, Cancer, NHS, NICE, NSCLC, lilly, pemetrexed
Eli Lilly is coming to terms with rejection by NICE after the cost watchdog said it would not recommend Alimta …
Lilly’s diabetes drug matches Victoza
February 26, 2014Research and Development, Sales and Marketing EMA, FDA, Victoza, dulaglutide, lilly
Eli Lilly’s once-weekly diabetes candidate dulaglutide has matched Novo Nordisk’s established once-daily Victoza (liraglutide) when it comes to lowering blood …
EFPIA appoints comms head from Lilly
February 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, English, liam, lilly
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has hired its new comms director from Eli Lilly. Liam English …
Sanofi files Lilly lawsuit
February 3, 2014Sales and Marketing FDA, Lantus, Sanofi, lilly
A row which has been brewing between Sanofi and Eli Lilly & Company has now erupted with the French manufacturer …
Lilly to go ‘on offense’
January 31, 2014Sales and Marketing Alimta, Lechleiter, cymbalta, lilly, q4, zyprexa
The loss of patent on antidepressant Cymbalta in the US last December was largely responsible for Eli Lilly & Co’s …
China ban for corrupt pharma firms
January 2, 2014Medical Communications, Sales and Marketing Cameron, China, GSK, Witty, bribery, lilly
Lilly signs Lou Gehrig’s disease deal
November 21, 2013Research and Development, Sales and Marketing als, hill, lilly, lou gehrig
Eli Lilly & Company has signed a deal with US charity Project A.L.S. to find new treatments for the debilitating …
Lilly plans $700m insulin plant expansion programme
November 18, 2013Manufacturing and Production Taylor, lilly, manufacturing
Eli Lilly has said it will invest more than $700 million to expand its production capacity for insulin products in …
Banker joins Lilly Board
October 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing jackson tai, lilly
Eli Lilly has appointed ex-investment banker Jackson Tai to its Board to serve on the Audit and Finance Committee from …
Lilly staff ‘divulged secrets’
October 10, 2013Medical Communications, Sales and Marketing China, bribery, lilly
Two former staff from Eli Lilly & Company have been accused in a US court of passing on industrial secrets …
Latest content
FibroFind appoints Lee Borthwick as CEO
